Literature DB >> 465875

Effects of beta 2-adrenoceptor stimulation on cardiac metabolism in the conscious dog.

E A Shanahan, M L Wahlqvist, E G Wilmshurst.   

Abstract

1 The effects of the beta 2-adrenoceptor stimulant, salbutamol, on cardiac metabolism have been studied in conscious mongrel dogs. The potential effects of anaesthesia on the study of cardiac metabolism have been avoided by prior implantation of arterial (A) and coronary sinus (CS) catheters for blood sampling and a central venous catheter for infusion. Extraction of substrates for myocardial energy metabolism (CA-CS) was assessed 3 to 24 days post-operatively. A 100 micrograms bolus of salbutamol was given followed by an infusion of 3 micrograms/min for 1 h. 2 Although heart rate increased significantly from 106 to 165 beats/min, fractional extraction of oxygen tended to fall from 84% to 77%. Thus an increase in coronary blood flow rather than in oxygen extraction must have maintained an oxygen supply commensurate with the salbutamol-induced tachycardia. 3 Neither CA-CS glucose nor fractional glucose extraction altered significantly during salbutamol infusion despite increases in arterial concentration (CA) of glucose and arterial insulin immunoreactivity and a decrease in CA of free fatty acids (FFA). This suggests that an insulin-antagonistic action accompanies the infusion of salbutamol. 4 The fractional extraction of lactate increased during salbutamol infusion. In part, this may have been a reflection of a decreased myocardial extraction of FFA with salbutamol in this model.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 465875      PMCID: PMC2043634          DOI: 10.1111/j.1476-5381.1979.tb13670.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  20 in total

1.  THE COLORIMETRIC MICRO-DETERMINATION OF NON-ESTERIFIED FATTY ACIDS IN PLASMA.

Authors:  W G DUNCOMBE
Journal:  Clin Chim Acta       Date:  1964-02       Impact factor: 3.786

2.  Immunoassay of insulin with insulin-antibody precipitate.

Authors:  C N HALES; P J RANDLE
Journal:  Biochem J       Date:  1963-07       Impact factor: 3.857

3.  Titration of free fatty acids of plasma: a study of current methods and a new modification.

Authors:  D L TROUT; E H ESTES; S J FRIEDBERG
Journal:  J Lipid Res       Date:  1960-04       Impact factor: 5.922

4.  The action of beta-adrenergic blocking and stimulating agents on insulin secretion. Characterization of the type of beta receptor.

Authors:  A Loubatières; M M Mariani; G Sorel; L Savi
Journal:  Diabetologia       Date:  1971-06       Impact factor: 10.122

5.  Intravenous salbutamol and cardiogenic shock.

Authors:  S Lal; R S Savidge; D M Davies; M M Ali; V Soni
Journal:  Lancet       Date:  1972-04-15       Impact factor: 79.321

6.  Myocardial lipid and carbohydrate metabolism in fasting men during prolonged exercise.

Authors:  L Kaijser; B W Lassers; M L Wahlqvist; L A Carlson
Journal:  J Appl Physiol       Date:  1972-06       Impact factor: 3.531

7.  Metabolic effects of oral salbutamol.

Authors:  M W Taylor; J Gaddie; L E Murchison; K N Palmer
Journal:  Br Med J       Date:  1976-01-03

Review 8.  Medical therapy of acute myocardial infarction by application of hemodynamic subsets (first of two parts).

Authors:  J S Forrester; G Diamond; K Chatterjee; H J Swan
Journal:  N Engl J Med       Date:  1976-12-09       Impact factor: 91.245

9.  Effect of intravenous injection of salbutamol in asthma.

Authors:  C S May; J W Paterson; S G Spiro; A J Johnson
Journal:  Br J Clin Pharmacol       Date:  1975-12       Impact factor: 4.335

10.  Correlative classification of clinical and hemodynamic function after acute myocardial infarction.

Authors:  J S Forrester; G A Diamond; H J Swan
Journal:  Am J Cardiol       Date:  1977-02       Impact factor: 2.778

View more
  1 in total

1.  Beta 1- and beta 2-adrenoceptor binding and functional response in right and left atria of rat heart.

Authors:  E N Juberg; K P Minneman; P W Abel
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-09       Impact factor: 3.000

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.